Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV
Different immunogens such as subunit, DNA or live viral-vectored vaccines against Infectious Bursal Disease virus (IBDV) have been evaluated in the last years. However, the heterologous prime-boost approach using recombinant modified vaccinia Ankara virus (rMVA), which has shown promising results in...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Inglés |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/959 http://ac.els-cdn.com/S0264410X16310763/1-s2.0-S0264410X16310763-main.pdf?_tid=4259e874-80ed-11e7-aeb2-00000aacb35e&acdnat=1502714397_5c2be71d1c7bb8e4cfed2165b1e4677d https://doi.org/10.1016/j.vaccine.2016.11.029 |
Ejemplares similares: Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV
- Molecular characterization of infectious bursal disease virus (IBDV) isolated in Argentina indicates a regional lineage
- Transient expression of VP2 in Nicotiana benthamiana and its use as a plant-based vaccine against Infectious Bursal Disease Virus
- Plant-based vaccine candidate against Infectious bursal disease: an alternative to inactivated vaccines for breeder hens
- Double-layered rotavirus-like particles are efficient carriers to elicit strong CTL responses to delivered heterologous antigens
- Development of diagnostic tools for IBDV detection using plants as bioreactors
- Infectious Bursal Disease Virus non-structural protein VP5 is not a transmembrane protein